State Street’s Zentalis Pharmaceuticals ZNTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $315K | Sell |
271,790
-1,047,995
| -79% | -$1.22M | ﹤0.01% | 3720 |
|
|
2025
Q1 | $2.1M | Buy |
1,319,785
+30,800
| +2% | +$49K | ﹤0.01% | 3229 |
|
|
2024
Q4 | $3.91M | Buy |
1,288,985
+42,372
| +3% | +$128K | ﹤0.01% | 3064 |
|
|
2024
Q3 | $4.59M | Sell |
1,246,613
-1,805,779
| -59% | -$6.65M | ﹤0.01% | 3006 |
|
|
2024
Q2 | $12.5M | Sell |
3,052,392
-733,260
| -19% | -$3M | ﹤0.01% | 2431 |
|
|
2024
Q1 | $59.7M | Sell |
3,785,652
-631,404
| -14% | -$9.95M | ﹤0.01% | 1629 |
|
|
2023
Q4 | $66.9M | Buy |
4,417,056
+1,713,696
| +63% | +$26M | ﹤0.01% | 1542 |
|
|
2023
Q3 | $54.2M | Sell |
2,703,360
-449,554
| -14% | -$9.02M | ﹤0.01% | 1574 |
|
|
2023
Q2 | $88.9M | Buy |
3,152,914
+320,891
| +11% | +$9.05M | ﹤0.01% | 1301 |
|
|
2023
Q1 | $48.7M | Sell |
2,832,023
-252,114
| -8% | -$4.34M | ﹤0.01% | 1666 |
|
|
2022
Q4 | $62.1M | Buy |
3,084,137
+233,963
| +8% | +$4.71M | ﹤0.01% | 1485 |
|
|
2022
Q3 | $61.7M | Sell |
2,850,174
-269,560
| -9% | -$5.84M | ﹤0.01% | 1455 |
|
|
2022
Q2 | $87.7M | Buy |
3,119,734
+1,039,294
| +50% | +$29.2M | 0.01% | 1253 |
|
|
2022
Q1 | $96M | Buy |
2,080,440
+734,024
| +55% | +$33.9M | ﹤0.01% | 1323 |
|
|
2021
Q4 | $113M | Buy |
1,346,416
+54,153
| +4% | +$4.55M | 0.01% | 1197 |
|
|
2021
Q3 | $86.1M | Sell |
1,292,263
-47,077
| -4% | -$3.14M | ﹤0.01% | 1397 |
|
|
2021
Q2 | $71.3M | Sell |
1,339,340
-129,851
| -9% | -$6.91M | ﹤0.01% | 1574 |
|
|
2021
Q1 | $63.7M | Buy |
1,469,191
+577,682
| +65% | +$25.1M | ﹤0.01% | 1565 |
|
|
2020
Q4 | $46.3M | Buy |
891,509
+729,915
| +452% | +$37.9M | ﹤0.01% | 1688 |
|
|
2020
Q3 | $5.28M | Buy |
161,594
+24,324
| +18% | +$795K | ﹤0.01% | 2752 |
|
|
2020
Q2 | $6.59M | Buy |
+137,270
| New | +$6.59M | ﹤0.01% | 2627 |
|